隆突性皮肤纤维肉瘤：对伊马替尼治疗的部分反应。 - Suppr

Dermatofibrosarcoma protuberans: a partial response to imatinib therapy.

作者信息

Mehrany Khosrow, Swanson Neil A, Heinrich Michael C, Weenig Roger H, Lee Ken K, White Clifton R, Devere Theresa S

机构信息

Department of Dermatology, Oregon Health and Science University, and Oregon Health and Cancer Institute, Portland, Oregon 97239, USA.

出版信息

Dermatol Surg. 2006 Mar;32(3):456-9. doi: 10.1111/j.1524-4725.2006.32090.x.

DOI:10.1111/j.1524-4725.2006.32090.x

PMID:16640697

Abstract

摘要

相似文献

Dermatofibrosarcoma protuberans: a partial response to imatinib therapy.

Dermatol Surg. 2006 Mar;32(3):456-9. doi: 10.1111/j.1524-4725.2006.32090.x.

Imatinib mesylate in the treatment of a large unresectable dermatofibrosarcoma protuberans: a case study.

Dermatol Surg. 2006 Aug;32(8):1097-102. doi: 10.1111/j.1524-4725.2006.32236.x.

Imatinib mesylate in a patient with metastatic disease originating from a dermatofibrosarcoma protuberans of the scalp.

Anticancer Drugs. 2006 Nov;17(10):1223-5. doi: 10.1097/01.cad.0000231486.94191.65.

Imatinib mesylate inhibits the growth of metastatic lung lesions in a patient with dermatofibrosarcoma protuberans.

Br J Dermatol. 2004 Jul;151(1):235-7. doi: 10.1111/j.1365-2133.2004.06024.x.

J Eur Acad Dermatol Venereol. 2010 Feb;24(2):244-5. doi: 10.1111/j.1468-3083.2009.03404.x. Epub 2009 Aug 20.

Imatinib mesylate as a preoperative therapy in dermatofibrosarcoma: results of a multicenter phase II study on 25 patients.

Clin Cancer Res. 2010 Jun 15;16(12):3288-95. doi: 10.1158/1078-0432.CCR-09-3401. Epub 2010 May 3.

Treatment of advanced dermatofibrosarcoma protuberans with imatinib mesylate with or without surgical resection.

J Eur Acad Dermatol Venereol. 2011 Mar;25(3):264-70. doi: 10.1111/j.1468-3083.2010.03774.x.

Letter: clear margins after the use of imatinib mesylate prior to resection of extensive dermatofibrosarcoma protuberans.

Dermatol Surg. 2008 Aug;34(8):1151. doi: 10.1111/j.1524-4725.2008.34234.x. Epub 2008 May 28.

Neoadjuvant imatinib therapy for dermatofibrosarcoma protuberans.

Arch Dermatol. 2009 Jul;145(7):792-6. doi: 10.1001/archdermatol.2009.140.

[Targeted therapy of dermatofibrosarcoma with imatinib].

J Dtsch Dermatol Ges. 2007 Mar;5(3):261. doi: 10.1111/j.1610-0387.2007.07009.x.

引用本文的文献

A case report of abdominal metastatic dermatofibrosarcoma protuberans misdiagnosed as gastrointestinal stromal tumor.

Diagn Pathol. 2024 Feb 22;19(1):41. doi: 10.1186/s13000-023-01430-9.

Surgical and Functional Considerations of Dermatofibrosarcoma Protuberans Involving Facial Nerve Danger Zones.

J Clin Aesthet Dermatol. 2019 Dec;12(12):39-43. Epub 2019 Dec 1.

Dermatofibrosarcoma protuberans - the use of neoadjuvant imatinib for treatment of an uncommon breast malignancy: a case report.

J Med Case Rep. 2019 Dec 19;13(1):374. doi: 10.1186/s13256-019-2316-0.

Dermatofibrosarcoma Protu-Berans with Lung Metastasis Requiring Pneumonectomy.

Rare Tumors. 2015 Dec 29;7(4):5981. doi: 10.4081/rt.2015.5981.

Neoadjuvant treatment of Dermatofibrosarcoma Protuberans of pancreas with Imatinib: case report and systematic review of literature.

Clin Sarcoma Res. 2014 Aug 6;4:8. doi: 10.1186/2045-3329-4-8. eCollection 2014.

Dermatofibrosarcoma protuberans: A rare cutaneous tumour.

J Surg Case Rep. 2012 Jul 1;2012(7):8. doi: 10.1093/jscr/2012.7.8.

Dermatofibrosarcoma protuberans (DFSP) successfully treated with sorafenib: case report.

Clin Sarcoma Res. 2013 Apr 4;3(1):5. doi: 10.1186/2045-3329-3-5.

Current treatment options in dermatofibrosarcoma protuberans.

J Cancer Res Clin Oncol. 2009 May;135(5):653-65. doi: 10.1007/s00432-009-0550-3. Epub 2009 Feb 10.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Dermatofibrosarcoma protuberans: a partial response to imatinib therapy.

作者信息

Mehrany Khosrow, Swanson Neil A, Heinrich Michael C, Weenig Roger H, Lee Ken K, White Clifton R, Devere Theresa S

机构信息

Department of Dermatology, Oregon Health and Science University, and Oregon Health and Cancer Institute, Portland, Oregon 97239, USA.

出版信息

Dermatol Surg. 2006 Mar;32(3):456-9. doi: 10.1111/j.1524-4725.2006.32090.x.

DOI:10.1111/j.1524-4725.2006.32090.x

PMID:16640697

Abstract

摘要

相似文献

Dermatofibrosarcoma protuberans: a partial response to imatinib therapy.

Dermatol Surg. 2006 Mar;32(3):456-9. doi: 10.1111/j.1524-4725.2006.32090.x.

Imatinib mesylate in the treatment of a large unresectable dermatofibrosarcoma protuberans: a case study.

Dermatol Surg. 2006 Aug;32(8):1097-102. doi: 10.1111/j.1524-4725.2006.32236.x.

Imatinib mesylate in a patient with metastatic disease originating from a dermatofibrosarcoma protuberans of the scalp.

Anticancer Drugs. 2006 Nov;17(10):1223-5. doi: 10.1097/01.cad.0000231486.94191.65.

Imatinib mesylate inhibits the growth of metastatic lung lesions in a patient with dermatofibrosarcoma protuberans.

Br J Dermatol. 2004 Jul;151(1):235-7. doi: 10.1111/j.1365-2133.2004.06024.x.

J Eur Acad Dermatol Venereol. 2010 Feb;24(2):244-5. doi: 10.1111/j.1468-3083.2009.03404.x. Epub 2009 Aug 20.

Imatinib mesylate as a preoperative therapy in dermatofibrosarcoma: results of a multicenter phase II study on 25 patients.

Clin Cancer Res. 2010 Jun 15;16(12):3288-95. doi: 10.1158/1078-0432.CCR-09-3401. Epub 2010 May 3.

Treatment of advanced dermatofibrosarcoma protuberans with imatinib mesylate with or without surgical resection.

J Eur Acad Dermatol Venereol. 2011 Mar;25(3):264-70. doi: 10.1111/j.1468-3083.2010.03774.x.

Letter: clear margins after the use of imatinib mesylate prior to resection of extensive dermatofibrosarcoma protuberans.

Dermatol Surg. 2008 Aug;34(8):1151. doi: 10.1111/j.1524-4725.2008.34234.x. Epub 2008 May 28.

Neoadjuvant imatinib therapy for dermatofibrosarcoma protuberans.

Arch Dermatol. 2009 Jul;145(7):792-6. doi: 10.1001/archdermatol.2009.140.

[Targeted therapy of dermatofibrosarcoma with imatinib].

J Dtsch Dermatol Ges. 2007 Mar;5(3):261. doi: 10.1111/j.1610-0387.2007.07009.x.

引用本文的文献

A case report of abdominal metastatic dermatofibrosarcoma protuberans misdiagnosed as gastrointestinal stromal tumor.

Diagn Pathol. 2024 Feb 22;19(1):41. doi: 10.1186/s13000-023-01430-9.

Surgical and Functional Considerations of Dermatofibrosarcoma Protuberans Involving Facial Nerve Danger Zones.

J Clin Aesthet Dermatol. 2019 Dec;12(12):39-43. Epub 2019 Dec 1.

Dermatofibrosarcoma protuberans - the use of neoadjuvant imatinib for treatment of an uncommon breast malignancy: a case report.

J Med Case Rep. 2019 Dec 19;13(1):374. doi: 10.1186/s13256-019-2316-0.

Dermatofibrosarcoma Protu-Berans with Lung Metastasis Requiring Pneumonectomy.

Rare Tumors. 2015 Dec 29;7(4):5981. doi: 10.4081/rt.2015.5981.

Neoadjuvant treatment of Dermatofibrosarcoma Protuberans of pancreas with Imatinib: case report and systematic review of literature.

Clin Sarcoma Res. 2014 Aug 6;4:8. doi: 10.1186/2045-3329-4-8. eCollection 2014.

Dermatofibrosarcoma protuberans: A rare cutaneous tumour.

J Surg Case Rep. 2012 Jul 1;2012(7):8. doi: 10.1093/jscr/2012.7.8.

Dermatofibrosarcoma protuberans (DFSP) successfully treated with sorafenib: case report.

Clin Sarcoma Res. 2013 Apr 4;3(1):5. doi: 10.1186/2045-3329-3-5.

Current treatment options in dermatofibrosarcoma protuberans.

J Cancer Res Clin Oncol. 2009 May;135(5):653-65. doi: 10.1007/s00432-009-0550-3. Epub 2009 Feb 10.

Dermatofibrosarcoma protuberans: a partial response to imatinib therapy.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

Dermatofibrosarcoma protuberans: a partial response to imatinib therapy.

作者信息

机构信息

出版信息

相似文献

引用本文的文献